Mycosis Fungoides and Sezary Syndrome — Sources & provenance

Mycosis Fungoides and Sezary Syndrome — Sources & provenance · CancerIndex

Provenance

Sources contributing to this entity

Every source that supplied a code, alias, edge, observation or derived value, with the ingest runs involved.

Source	License	Contributions	Ingest runs	Last retrieved
CIViC — Clinical Interpretation of Variants in Cancer civic	approved	Evidence	ING-CIVIC-20260930-000001	Sep 30, 2026, 02:01 AM UTC
EMA — European public assessment reports (centrally authorised medicines) ema	approved	Approvals	—	Sep 16, 2026, 05:01 AM UTC
NCI Thesaurus (NCIt) ncit-evs	approved	Aliases, Codes, Description, Hierarchy, Source Records	ING-NCITEVS-20260908-000001	Sep 8, 2026, 09:44 AM UTC
openFDA — Drugs@FDA applications and drug labels (SPL) openfda	approved	Approvals	—	Sep 28, 2026, 04:05 AM UTC
PubMed (NCBI E-utilities) pubmed	approved	Literature Counts	ING-PUBMED-20260926-000001	Sep 26, 2026, 03:00 AM UTC

Identifiers

Every upstream identifier is kept with its match type; nothing is buried in JSON.

System	Code	Match type	Source
NCIt	C9265	EXACT_IDENTIFIER	ncit-evs

Names

Alias	Type	Terminology	Language
Mycosis Fungoides and Sezary Syndrome	preferred	NCIt	en

Change history

Creation, updates, merges and ranking changes recorded for this entity.

CreatedCreated from NCIt C9265 (Mycosis Fungoides and Sezary Syndrome)Sep 8, 2026
ING-NCITEVS-20260908-000001